title: Molecular Targets and Treatment of Meningioma.
abstract: Meningiomas are by far the most common tumors arising from the meninges. A myriad of aberrant signaling pathways involved with meningioma tumorigenesis, have been discovered. Understanding these disrupted pathways will aid in deciphering the relationship between various genetic changes and their downstream effects on meningioma pathogenesis. An understanding of the genetic and molecular profile of meningioma would provide a valuable first step towards developing more effective treatments for this intracranial tumor. Chromosomes 1, 10, 14, 22, their associated genes, and other potential targets have been linked to meningioma proliferation and progression. It is presumed that through an understanding of these genetic factors, more educated meningioma treatment techniques can be implemented. Future therapies will include combinations of targeted molecular agents including gene therapy, si-RNA mediation, proton therapy, and other approaches as a result of continued progress in the understanding of genetic and biological changes associated with meningiomas. This review provides an overview of the current knowledge of the genetic, signaling and molecular profile of meningioma and possible treatments strategies associated with such profiles.
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Rickey
authors.initials: R
authors.lastname: Miller
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Michele L
authors.initials: ML
authors.lastname: DeCandio
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Yaenette
authors.initials: Y
authors.lastname: Dixon-Mah
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Pierre
authors.initials: P
authors.lastname: Giglio
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: W Alex
authors.initials: WA
authors.lastname: Vandergrift
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA ; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
authors.forename: Naren L
authors.initials: NL
authors.lastname: Banik
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Sunil J
authors.initials: SJ
authors.lastname: Patel
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Abhay K
authors.initials: AK
authors.lastname: Varma
authors.affiliation: Department of Neurosciences (Divisions of Neurology and Neurosurgery) & MUSC Brain & Spine Tumor Program Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Arabinda
authors.initials: A
authors.lastname: Das
keywords: Meningioma; Merlin; Molecular genetics; NF2; Proliferation; Tumorgenesis